Table 10 Hazard ratios (CCLG vs. GPOH) according to local treatment modality, among patients with localised disease only

No. events

 EFS

62

42

83

61

22

 OS

53

33

66

49

17

Unadjusted

 EFS

0.89 (0.54–1.46)

1.44 (0.78–2.64)

1.66 (0.94–2.96)

2.44 (0.76–7.81)

2.36 (1.02–5.45)

 OS

0.99 (0.56–1.64)

1.74 (0.86–3.51)

1.60 (0.84–3.06)

2.70 (0.84–8.73)

2.03 (0.78–5.28)

Adjusted for age, primary site and histology

 EFS

0.98 (0.58–1.66)

1.51 (0.78–2.94)

1.65 (0.91–2.99)

2.39 (0.71–8.05)

2.12 (0.83–5.40)

 OS

1.10 (0.62–1.95)

1.94 (0.89–4.25)

1.50 (0.77–2.93)

3.10 (0.90–10.70)

1.74 (0.60–5.08)

Adjusted for age, primary site, histology and time between the start of chemotherapy and starting local treatment

 EFS

0.95 (0.54–1.67)

1.48 (0.76–2.89)

1.48 (0.81–2.69)

1.69 (0.50–5.68)

2.10 (0.82–5.41)

 OS

1.03 (0.55–1.90)

1.92 (0.87–4.24)

1.39 (0.71–2.74)

2.49 (0.72–8.58)

1.74 (0.59–5.10)